London Daily

Focus on the big picture.
Sunday, Aug 10, 2025

Coronavirus: Vaccine chief 'optimistic' about over-50s May target

Coronavirus: Vaccine chief 'optimistic' about over-50s May target

The UK can meet the target of vaccinating all over-50s by May, the chairman of the vaccines taskforce has said, adding he is "very optimistic".

Dr Clive Dix told the BBC the taskforce has met every target set.

The UK would be "ahead of the game" in terms of anticipating variants of coronavirus and was making "libraries of future vaccines", he said.

He added that the UK would not hoard supplies but would distribute them globally, once the UK target is met.

Downing Street has said everyone in the UK aged 50 and over should have been offered a coronavirus vaccine by May.

Previously, ministers had said it was their "ambition" to vaccinate the first nine priority groups by the spring.

As of Friday, the UK had given a first jab to nearly 11.5 million people and is aiming to reach 15 million vaccinations by 15 February.

The latest figures also showed another 828 people in the UK have died within 28 days of a positive Covid test, and there were a further 18,262 cases.

Dr Dix, who heads the government unit charged with developing and producing vaccines, told BBC Radio 4's Today programme: "We will work day and night to ensure we meet whatever the target that's feasible can be met.

"So I'm very optimistic that we will meet the May target."

Questions have been raised around the efficacy of vaccines against variants of the virus - including the one first identified in Kent.

On Friday, Oxford-AstraZeneca said its vaccine gave people good protection against the UK variant.

Variants in South Africa and Brazil have also been identified.

Dr Dix, who is also chief executive of drug discovery company C4X Discovery, said the UK was "at the forefront of surveying" the variants, allowing scientists to "second-guess" mutations that have not yet occurred.

They can then make vaccines for those variants, he told the programme.

"We'll make libraries of future vaccines, just small amounts, enough to then, if it does occur, do a quick clinical study to see that it works and then start manufacturing it," he said.



Hitting this target is all about vaccine supply


The NHS has the staff, the volunteers and the clinics needed to vaccinate the 15 million in these next priority groups as well as give second doses to those who have already had their first jab.

But vaccine production is a biological process so there are no guarantees about how much can be grown.

However, there is growing confidence in the UK supply chain.

The bulk of the supplies are now coming from UK-based plants producing the Oxford-AstraZeneca vaccine and the yields from these are now consistently in line with expectation unlike those in Europe which started producing the vaccine later and have had less time to iron out the teething problems.

On top of this, supplies from Pfizer-BioNTech are expected to increase from mid-February after a slowdown in recent weeks.

There will also be a third vaccine made by US firm Moderna to help. The first batches of the 17 million ordered will start arriving before Easter.

It will all be needed as there can be no let up if the over-50s are to get vaccinated in the timeframe set out.
2px presentational grey line

Asked whether there could be a vaccine-busting variant at some stage, Dr Dix said: "There's a possibility, but we'll be ahead of the game, we're not going to be waiting for it to happen.

"We now have the capabilities in the UK to be responsive and that capability won't just be for the use of the UK of course.

"Once we've done it, it will actually help the whole world because it will be part of that whole surveillance and reaction."

Speaking to BBC Breakfast, former Health Secretary Jeremy Hunt warned that mutations of the virus could lead to a "cycle" of lockdowns in the future if measures were not put in place, such as effective contact tracing.

"The worry that we have to really plan for is the possibility that we will have a new mutation that is actually immune to the vaccines that we're giving out at the moment," Mr Hunt said.

"So, in order to make sure that we don't get caught out by that again, we need to get transmission levels down to the kind of levels where we can do incredibly thorough contact tracing, like they do in Korea and Taiwan."

He also repeated his call for the government to consider more financial support for people told to self-isolate by NHS contact tracers, for example by offering to "make up any salary losses".

Despite the promising news over vaccines, doctors have warned against relaxing rules too quickly.

Dr Daniele Bryden, a consultant in intensive care medicine at Sheffield Teaching Hospitals, told Today: "I think the vaccination is really encouraging, but we really can't let our guard down and relax the rules.

"For example, the average age of a patient on intensive care at the moment is only 60 and 40% of people on intensive care are less than that age. So it's going to take some time before we see the impact of vaccination."



Every adult in the UK will be offered a vaccine by the autumn, Health Secretary Matt Hancock said last month.

Meanwhile, surge testing is being rolled out to further areas to control and suppress the spread of coronavirus variants, including in:

*  targeted areas around Worcestershire

*  an area in Sefton, Merseyside (PR9)

*  and areas in Bristol and South Gloucestershire

The Department for Health and Social Care said people living in targeted areas were "strongly encouraged" to take a Covid test this week, whether showing symptoms or not.

Testing for the South African variant is also due to be increased in Southport after a second case was detected.

Newsletter

Related Articles

0:00
0:00
Close
Street justice isn’t pretty but how else do you deal with this kind of insanity? Sometimes someone needs to standup and say something
Armenia and Azerbaijan sign U.S.-brokered accord at White House outlining transit link via southern Armenia
Barcelona Resolves Captaincy Issue with Marc-André ter Stegen
US Justice Department Seeks Release of Epstein and Maxwell Grand Jury Exhibits Amid Legal and Victim Challenges
Trump Urges Intel CEO Lip-Bu Tan to Resign Over Alleged Chinese Business Ties
Scotland’s First Minister Meets Trump Amid Visit Highlighting Whisky Tariffs, Gaza Crisis and Heritage Links
Trump Administration Increases Reward for Arrest of Venezuelan President Maduro to Fifty Million Dollars
Armenia and Azerbaijan to Sign US-Brokered Framework Agreement for Nakhchivan Corridor
British Labour Government Utilizes Counter-Terrorism Tools for Social Media Monitoring Against Legitimate Critics
OpenAI Launches GPT‑5, Its Most Advanced AI Model Yet
Embarrassment in Britain: Homelessness Minister Evicted Tenants and Forced to Resign
President Trump nominated Stephen Miran, his top economic adviser and a critic of the Federal Reserve, to temporarily fill an open Fed seat
The AI-Powered Education Revolution: Market Potential and Transformative Impact
Chikungunya Virus Outbreak in Southern China: Over 7,000 Hospitalized
French wine makers have seen catastrophic damage to vines that were almost ready to be harvested after the worst fires in more than 70 years burned through the south of the country
US Lawmaker Probes Intel CEO’s China Ties Amid National Security Concerns
Brazilian President Lula says he’ll contact the leaders of BRICS states to propose a unified response to U.S. tariffs
Trump Open to Meeting Putin as Soon as Next Week, with Possible Trilateral Summit Including Zelenskiy
Katy Perry and Justin Trudeau spark dating rumors, joining high stakes world of celeb-politician romances
US envoy Steve Witkoff arrived in Moscow to seek a breakthrough in the Ukraine war ahead of President Trump’s peace deadline
WhatsApp Deletes 6.8 Million Scam Accounts Amid Rising Global Fraud
Nine people have been hospitalized and dozens of salmonella cases have been reported after an outbreak of infections linked to certain brands of pistachios and pistachio-containing products, according to the Public Health Agency of Canada
Karol Nawrocki Inaugurated as Poland’s President, Setting Stage for Clash with Tusk Government
Trump Signals JD Vance as ‘Most Likely’ MAGA Successor for 2028
US Charges Two Chinese Nationals for Illegal Nvidia AI Chip Exports
Texas Residents Face Water Restrictions While AI Data Centers Consume Millions of Gallons
U.S. Tariff Policy Triggers Market Volatility Amid Growing Global Trade Tensions
Tariffs, AI, and the Shifting U.S. Macro Landscape: Navigating a New Economic Regime
Representative Greene Urges H-1B Visa Cuts Amid U.S.-India Trade Tensions
U.S. House Committee Subpoenas Clintons and Senior Officials in Epstein Investigation
Sydney Sweeney Registered as Republican as Controversial American Eagle Ad Sparks Debate
Trump Accuses Major Banks of Politically Motivated Account Denials and Prepares Executive Order
TikTok Removes Huda Kattan Video Over Anti-Israel Conspiracy Claims
Trump Threatens Tariffs on India Over Russian Oil Imports
German Finance Minister Criticizes Trump’s Attacks on Institutions
U.S. Proposes Visa Bond of Up to $15,000 for Some Applicants
U.S. Farmers Increase Lobbying Amid Immigration Crackdown
Elon Musk Receives $23.7 Billion Tesla Stock Award
Texas House Paralyzed After Democrats Walk Out Over Redistricting
Mexican Cartels Complicate Sheinbaum’s U.S. Security Talks
Mark Zuckerberg Declares War on the iPhone
India Rejects U.S. Tariff Threat, Defends Russian Oil Purchases
United States Establishes Strategic Bitcoin Reserve and Digital Asset Stockpile
Thousands of Private ChatGPT Conversations Accidentally Indexed by Google
China Tightens Mineral Controls, Curtailing Critical Inputs for Western Defence Contractors
OpenAI’s Bold Bet: Teaching AI to Think, Not Just Chat
Tesla Seeks Shareholder Approval for $29 Billion Compensation Package for Elon Musk
Nvidia is cutting prices on its RTX 50-series graphics cards after sales slowed and inventories piled up
Ghislaine Maxwell Transferred to Minimum-Security Prison Amid Ongoing DOJ Discussions
U.S. Tariffs Surge to Highest Levels in Nearly a Century Under Second Trump Term
×